Cefazolin and Enterobacteriaceae: Rationale for Revised Susceptibility Testing Breakpoints

J. D. Turnidge
2011 Clinical Infectious Diseases  
doi:10.1093/cid/cir031 pmid:21427400 fatcat:fgkviydgsrannkb3ieczk5tpxu